Mesa Laboratories (MLAB) Stock Statistics & Valuation Metrics

Mesa Laboratories has a market cap or net worth of $596.94M. The enterprise value is $896.58M.

Mesa Laboratories has 5.43M shares outstanding. The number of shares has decreased by -2.65% in one year.

Mesa Laboratories’s return on equity (ROE) is -1.75 and return on invested capital (ROIC) is -61.89%.

The current PE Ratio of Mesa Laboratories is -2.37. Mesa Laboratories’s PEG ratio is <0.01.

In the last 12 months, Mesa Laboratories had revenue of $237.75M and earned -$249.44M in profits. Earnings per share was -$46.25.

In the last 12 months, operating cash flow was $47.03M and capital expenditures -$4.03M, giving a free cash flow of $43.00M billion.

Mesa Laboratories pays an annual dividend of $0.16, resulting in a dividend yield of 0.56%

Mesa Laboratories upcoming earnings date is Jun 9, 2025, TBA.

Mesa Laboratories as a current ratio of 2.47, with Debt / Equity ratio of 1.59

In the past 12 months, Mesa Laboratories has paid -$20.39M in taxes.

Mesa Laboratories EV to EBITDA ratio is -3.38, with an EV/FCF ratio of 19.40.

Mesa Laboratories has $30.96M in cash and marketable securities with $127.91M in debt, giving a net cash position of $96.96M billion.

Gross margin is 61.64%, with operating margin of -125.85%, and net profit margin of -117.60%.

The average price target for Mesa Laboratories is $120.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell